Superior Planning, LLC’s Praxis Precision Medicines PRAX Stock Holding History

Superior Planning, LLC’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21.3K	Buy	+73	New	+$24.2K	0.01%	674

Other funds holding PRAX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Superior Planning, LLC's PRAX Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 73 shares worth $21.3K. The stake represents 0.01% of the portfolio and ranks #674 among its holdings.

190 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

Superior Planning, LLC held 73 shares of Praxis Precision Medicines worth $21.3K as of Q3 2026.
Praxis Precision Medicines was a new Superior Planning, LLC position in Q3 2026.
Praxis Precision Medicines made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #674 holding.
190 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.